OutSee

OutSee

Private
CambridgeHealthcare & Life Scienceshttps://outsee.co.uk

Last Round

Seed

Jan 12, 2026

Total Funding Raised

$5.69M

Momentum Score

25 /100

Company Overview

OutSee is a biotechnology company developing and applying innovative computational approaches to genomics for drug target discovery and precision medicine.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

AI drug discoverydrug target discoverypredictive genomicsprecision medicinecomputational drug discoveryin silico drug discoverytechbioAI biotechcomputational biologyhypothesis-free discoverytarget identificationcausal biologydisease mechanism discoverygenomic data analysisrare diseasesCNS disordersmetabolic diseasespharma partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OutSee Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OutSee Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJan 12, 2026
SeedJun 24, 2025

Key People

Founding team and executive leadership

Julian Gough

Chief Executive Officer

Executive Team

James Peach

Chief Operating Officer

Executive Team

OutSee Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Developing lead drug target candidate with o2h discovery.

  • Jan 20, 2026

    Partnered with o2h discovery to develop a lead drug target candidate.

OutSee Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OutSee Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OutSee's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range9
Year Founded2022
Last FundingJan 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.